Suppr超能文献

在Hela细胞中,GRIM-19抑制通过激活ERK和HIF-1α而非STAT3诱导自噬。

GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.

作者信息

Yue Xin, Zhao Peiwei, Wu Kongming, Huang Juan, Zhang Wen, Wu Yaogui, Liang Xiaohui, He Xuelian

机构信息

Clinical Research Center, Wuhan Medical and Healthcare Center for Women and Children, No. 100 Hongkong Rd, Wuhan, Hubei, China.

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, China.

出版信息

Tumour Biol. 2016 Jul;37(7):9789-96. doi: 10.1007/s13277-016-4877-5. Epub 2016 Jan 25.

Abstract

Gene associated with retinoid-interferon-induced mortality (GRIM-19), an important subunit of mitochondrial complex I, has been identified as a tumor suppressor, and its reduced expression has been reported to be associated with tumorigenesis and metastasis. Autophagy has been proposed as a protective mechanism for cell survival under various stresses, including chemotherapy. However, it remains unknown whether GRIM-19 is linked to autophagy and chemotherapy resistance. Here, we showed that suppression of GRIM-19 by shRNA enhanced cell-type-dependent autophagy by activating extracellular regulated protein kinase (ERK) and hypoxia inducible factor-1a (HIF-1a) in a reactive oxygen species (ROS)-mediated manner, and thereby conferred resistance to paclitaxel. Besides, the antioxidant N-acetyl-L-cysteine (NAC) and autophagy inhibitor 3-MA could in part overcome this resistance. We also found that GRIM-19 expression was significantly correlated with clinical stage and grade in patients with cervical cancers. Taken together, our results indicated that GRIM-19 inhibition induced autophagy and chemotherapy resistance, which could affect prognosis of cervical cancers. Our study has identified new function of GRIM-19 and its underlying mechanism, and it will provide possible avenues for therapeutic targeting in cervical cancers.

摘要

与类视黄醇-干扰素诱导的死亡率相关的基因(GRIM-19)是线粒体复合体I的一个重要亚基,已被确定为一种肿瘤抑制因子,据报道其表达降低与肿瘤发生和转移有关。自噬被认为是细胞在包括化疗在内的各种应激下存活的一种保护机制。然而,GRIM-19是否与自噬和化疗耐药性相关仍不清楚。在此,我们表明,通过shRNA抑制GRIM-19以活性氧(ROS)介导的方式激活细胞外调节蛋白激酶(ERK)和缺氧诱导因子-1α(HIF-1α),从而增强细胞类型依赖性自噬,进而赋予对紫杉醇的抗性。此外,抗氧化剂N-乙酰-L-半胱氨酸(NAC)和自噬抑制剂3-MA可以部分克服这种抗性。我们还发现,GRIM-19表达与宫颈癌患者的临床分期和分级显著相关。综上所述,我们的结果表明,GRIM-19抑制诱导自噬和化疗耐药性,这可能影响宫颈癌的预后。我们的研究确定了GRIM-19的新功能及其潜在机制,并将为宫颈癌的治疗靶点提供可能的途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验